Zlobec, Inti
University of Bern,
Switzerland
2025 Rank: 78036
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3123 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 78036 | 79514 |
| Total Cites | 15281 | 17435 |
| H-index | 62 | 67 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 17 | 18 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 2245 | 2604 |
| Number of Single+First+Last Authored Papers | 87 | 87 |
| Total Cites to Single+First+Last Authored Papers | 3630 | 4203 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11889 | 12824 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.36 |
| Self-Citation Percentage |
12.35%
|
|
Zlobec, Inti
University of Bern,
Switzerland
2024 Rank: 78384
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3174 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 78384 | 78288 |
| Total Cites | 13512 | 15502 |
| H-index | 60 | 65 |
| Hm-index | 20 | 22 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 17 | 18 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 2109 | 2459 |
| Number of Single+First+Last Authored Papers | 85 | 85 |
| Total Cites to Single+First+Last Authored Papers | 3334 | 3888 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10564 | 11416 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.36 |
| Self-Citation Percentage |
12.84%
|
|
Zlobec, Inti
University of Bern,
Switzerland
2023 Rank: 80365
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3288 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 80365 | 80832 |
| Total Cites | 11780 | 13624 |
| H-index | 58 | 64 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 16 | 17 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 1978 | 2323 |
| Number of Single+First+Last Authored Papers | 82 | 82 |
| Total Cites to Single+First+Last Authored Papers | 3054 | 3588 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9216 | 9996 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.36 |
| Self-Citation Percentage |
13.53%
|
|
Zlobec, Inti
University of Bern, Institute of Pathology,
Switzerland
2022 Rank: 82725
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3351 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 82725 | 82746 |
| Total Cites | 9893 | 11562 |
| H-index | 53 | 59 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 16 | 17 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 1839 | 2171 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 2730 | 3223 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7722 | 8421 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.37 |
| Self-Citation Percentage |
14.44%
|
|
Zlobec, Inti
University of Bern, Institute of Pathology,
Switzerland
2021 Rank: 85413
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3440 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 85413 | 84436 |
| Total Cites | 9075 | 10685 |
| H-index | 50 | 56 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 14 | 15 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 1767 | 2095 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 2603 | 3092 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7119 | 7783 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.37 |
| Self-Citation Percentage |
15.07%
|
|
Zlobec, Inti
University of Bern,
Switzerland
2020 Rank: 95566
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3966 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 95566 | 92191 |
| Total Cites | 7068 | 8394 |
| H-index | 44 | 50 |
| Hm-index | 16 | 18 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 13 | 14 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 1595 | 1899 |
| Number of Single+First+Last Authored Papers | 68 | 68 |
| Total Cites to Single+First+Last Authored Papers | 2260 | 2694 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5567 | 6126 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.37 |
| Self-Citation Percentage |
15.80%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.